Pharmanex seeking court order to allow red yeast rice imports.
This article was originally published in The Tan Sheet
Executive Summary
PHARMANEX PRELIMINARY INJUNCTION HEARING SET FOR JUNE 15 in Salt Lake City federal court. At the hearing, the court will consider a request by Pharmanex for a preliminary injunction against FDA that would allow the company to resume import of Chinese red yeast rice for Cholestin at least until a final court decision is reached on whether the product is in compliance with the law. Pharmanex went back to court following FDA's May 20 decision that Cholestin is an unapproved new drug and may not be marketed as a dietary supplement.